The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 8,323 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
| ABEONA THERAPEUTICS INC | COM | 00289Y107 | 4,333 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 2,310 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
| ARAVIVE INC | COM | 03890D108 | 410 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 5,857 | 42,100 | SH | SOLE | 42,100 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,700 | 232,000 | SH | SOLE | 232,000 | 0 | 0 | ||
| AXONICS MODULATION TECH INC | COM | 05465P101 | 5,764 | 208,000 | SH | SOLE | 208,000 | 0 | 0 | ||
| BAXTER INTL INC | COM | 071813109 | 13,797 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 5,180 | 92,000 | SH | SOLE | 92,000 | 0 | 0 | ||
| CIGNA CORP NEW | COM | 125523100 | 6,135 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 3,862 | 214,500 | SH | SOLE | 214,500 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 3,704 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 4,156 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 4,462 | 780,000 | SH | SOLE | 780,000 | 0 | 0 | ||
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 6,299 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 7,776 | 130,400 | SH | SOLE | 130,400 | 0 | 0 | ||
| EXACT SCIENCES CORP | COM | 30063P105 | 2,867 | 31,000 | SH | SOLE | 31,000 | 0 | 0 | ||
| HCA HEALTHCARE INC | COM | 40412C101 | 9,268 | 62,700 | SH | SOLE | 62,700 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB LTD | SHS | G46188101 | 5,430 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 2,962 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 3,760 | 830,000 | SH | SOLE | 830,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 1,367 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,247 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 3,946 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 2,587 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,547 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
| NEXTCURE INC | COM | 65343E108 | 5,239 | 93,000 | SH | SOLE | 93,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 390 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 683 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 473 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 3,941 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 8,758 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 8,158 | 54,500 | SH | SOLE | 54,500 | 0 | 0 | ||